# EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus

> **NCT02632292** · NA · TERMINATED · sponsor: **University of Luebeck** · enrollment: 33 (actual)

## Conditions studied

- Coronary Artery Disease
- Diabetes Mellitus

## Interventions

- **DEVICE:** Absorb GT1
- **DEVICE:** Promus

## Key facts

- **NCT ID:** NCT02632292
- **Lead sponsor:** University of Luebeck
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01
- **Primary completion:** 2017-01-03
- **Final completion:** 2017-01-03
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2019-09-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02632292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02632292, "EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02632292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*